|
Louisa Nicola is a clinical neurophysiologist, researcher, and founder of Neuro Athletics who focuses on improving brain performance and reducing dementia risk through exercise, sleep, metabolic health, nutrition, and selected supplements. Her strongest message is that brain health depends heavily on physical health, especially cardiovascular fitness and maintaining muscle and strength as we age. She also promotes creatine, omega-3s, and other interventions, although some of her higher-dose supplement recommendations—such as 15–20 g/day of creatine for brain benefits—are promising but not yet supported by definitive long-term clinical evidence. Overall, she is a strong science communicator whose core lifestyle recommendations align well with current research on healthy brain aging. ChatGPT5.1 |
|
Louisa Nicola: A Five-Page Overview
Neurophysiology, Brain Performance, Exercise, and Alzheimer’s Prevention
1. Who Is Louisa Nicola?
Louisa Nicola is an Australian-born clinical neurophysiologist, human-performance coach, researcher, entrepreneur, and science communicator whose work focuses on protecting and improving the human brain. She is the founder of Neuro Athletics, a consulting and education company that applies neuroscience to cognitive performance, athletic performance, healthy aging, and the prevention of neurological disease. She is also the host of The Neuro Experience, a long-running podcast devoted to neuroscience, health, longevity, sleep, exercise, and human performance.
Nicola is particularly interesting because she occupies the intersection of two worlds that historically have not always been closely connected: exercise physiology and neuroscience. Rather than treating the brain as something that is primarily protected by crossword puzzles, medications, or intellectual activity, she argues that the brain is profoundly affected by what happens to the rest of the body. Muscle strength, cardiorespiratory fitness, blood pressure, metabolic health, sleep, diet and physical activity therefore become brain-health interventions as well as general health interventions.
Her current professional biography lists her as MMed, PhD(c). She holds a Master of Medicine in Clinical Neurophysiology from the University of Sydney and is pursuing doctoral research focused on neuroscience and Alzheimer's disease. Current biographical material describes her doctoral work as examining the effects of exercise, particularly resistance exercise, on the aging brain.
That credential distinction is worth making. Nicola is frequently called “Dr. Louisa Nicola” on podcasts and health websites, but the more precise description, based on her current professional biography, is clinical neurophysiologist and PhD candidate rather than medical doctor/physician. Her MMed is a postgraduate academic degree; it should not be confused automatically with an MD.
Before entering neuroscience, Nicola was a high-level triathlete who competed internationally for Australia. She has described a serious cycling accident as helping redirect her career toward medicine, neuroscience and understanding human performance. That athletic background remains central to her approach: she tends to think of the brain as an organ that can be trained, stressed, recovered and protected, much as an athlete approaches muscle and cardiovascular fitness.
2. Neuro Athletics and Her Central Philosophy
Nicola founded Neuro Athletics to apply neuroscience techniques to athletes, executives and other people working in high-pressure environments. Her clients have reportedly included professional athletes from the NBA, NFL and MLB as well as executives and finance professionals. Her approach has incorporated cognitive testing, laboratory measurements and EEG-based assessments in an attempt to understand an individual's neurological and physiological performance.
The central idea behind Neuro Athletics is surprisingly straightforward:
You cannot separate brain health from physical health.
Nicola therefore places far more emphasis on exercise, sleep and cardiovascular/metabolic health than on exotic “brain-training” products. Earlier in her career she frequently described three major pillars—sleep, exercise and nutrition—and those remain at the center of her recommendations.
Her philosophy has gradually expanded from optimizing elite performance to something much larger: extending cognitive health throughout aging and reducing the probability of Alzheimer’s disease and other dementias. Her recent public work increasingly emphasizes Alzheimer's prevention, particularly in middle-aged and older adults.
This is where Nicola's message resonates with modern dementia research. The 2024 Lancet Commission estimated that approximately 45% of dementia cases could potentially be prevented or delayed by addressing 14 modifiable risk factors across the lifespan. These include inadequate education, hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, excessive alcohol consumption, social isolation, air pollution and untreated vision loss.
Nicola sometimes describes Alzheimer's rather strongly as a “lifestyle-driven disease.” That wording goes farther than I would. Alzheimer's is a complex neurodegenerative disease involving aging, genetics, amyloid and tau pathology, vascular health, metabolic factors, inflammation and environmental exposures. Lifestyle can substantially modify risk, but a person cannot guarantee prevention simply by living correctly. The Alzheimer's Association likewise describes exercise and healthy eating as strategies that may lower risk, rather than claiming that Alzheimer's can currently be reliably prevented.
So the stronger scientific translation of Nicola's message is:
A very substantial fraction of dementia risk appears modifiable, even though Alzheimer's itself cannot presently be considered completely preventable.
3. Exercise: Probably the Strongest Part of Nicola's Message
If one idea dominates Nicola's work, it is that exercise is medicine for the brain.
She emphasizes both aerobic conditioning and resistance training but has become especially interested in muscle strength and resistance exercise. Her reasoning is that skeletal muscle is not merely mechanical tissue. Contracting muscle affects metabolism, cardiovascular function, insulin sensitivity and signaling molecules that can influence the nervous system.
Nicola coauthored a 2024 scientific narrative review titled “Does resistance training in older adults lead to structural brain changes associated with a lower risk of Alzheimer's dementia?” The authors concluded that preliminary research indicates resistance exercise can produce structural brain changes that may reduce Alzheimer's risk or slow processes associated with progression, while also emphasizing that the research remains incomplete.
Subsequent clinical evidence makes the idea even more interesting. A 2025 randomized study of older adults with mild cognitive impairment found that 24 weeks of resistance training improved verbal episodic memory, produced favorable changes in white-matter integrity, and appeared to protect portions of the hippocampus and precuneus from atrophy compared with controls. Those brain regions are important because they are affected during cognitive aging and Alzheimer's disease.
There is also compelling long-term observational evidence. Nicola frequently discusses a study involving female twins in which greater leg power predicted better cognitive aging and global brain structure roughly a decade later. The original research found that leg power was associated with subsequent cognition and brain structure even after accounting for shared genetics and early-life environment.
This doesn't mean doing squats will guarantee that someone avoids dementia. It means something more defensible: maintaining muscular strength appears to be one marker—and possibly one contributor—to healthier brain aging.
Nicola favors compound movements such as squats and deadlifts because they efficiently train large amounts of muscle. She also advocates aerobic exercise, higher-intensity cardiovascular work and regular daily movement rather than relying exclusively on strength training. In public discussions she has repeatedly presented exercise as the intervention she would put ahead of most supplements or expensive longevity technologies.
That priority is well supported. Higher levels of physical activity in middle and later life have repeatedly been associated with lower incidence of dementia, and randomized exercise studies increasingly demonstrate measurable effects on cognition and brain structure.
4. Sleep and Brain Recovery
The second pillar of Nicola's philosophy is sleep.
Her argument is broader than “sleep makes you feel rested.” Sleep affects memory consolidation, emotional regulation, metabolic function, hormonal signaling and the ability of the brain to maintain normal cellular function.
Nicola frequently emphasizes maintaining a regular sleep schedule, obtaining sufficient sleep and reducing behaviors that interfere with deep and restorative sleep. Her Neuro Athletics material has discussed sleep extensively since the early years of the company.
The relationship between sleep and dementia is scientifically intriguing but complicated. Poor sleep is associated with worse cognitive outcomes, while neurological disease itself can disrupt sleep. Consequently, cause and effect can run in both directions. It would therefore be too strong to say that simply sleeping eight hours prevents Alzheimer's.
The practical lesson is nevertheless sound. Treat sleep as a core component of brain health rather than disposable downtime.
Nicola's performance background also influences this thinking. To an athlete, recovery is part of training rather than the absence of training. She applies essentially the same principle to the nervous system: chronic stress combined with insufficient recovery eventually degrades performance.
5. Creatine: Nicola's Most Interesting—and Most Debatable—Recommendation
Creatine has become one of Nicola's most prominent subjects.
Creatine is best known as a sports supplement. Muscle cells use the creatine-phosphocreatine system to rapidly regenerate ATP, the cellular energy currency required during high-energy demand. The brain also contains creatine and uses the phosphocreatine system for energy buffering.
Nicola formerly recommended approximately 5 grams of creatine monohydrate per day, which is the conventional maintenance dose used for muscle performance. She later publicly revised that recommendation upward. In a 2025 interview she argued that 10 grams should be viewed as a starting point for brain effects, roughly 12–15 grams for many women, and as much as 15–20 grams per day for some men or people experiencing neurological stress.
She has explained the idea by saying that larger supplemental amounts are required to substantially increase creatine availability in the brain because brain creatine concentrations are more resistant to change than muscle creatine concentrations.
There is real science behind her enthusiasm.
A 2024 systematic review and meta-analysis of randomized controlled trials found evidence that creatine supplementation may improve some aspects of memory, attention and information-processing speed in adults, although the results were not universally positive.
A separate meta-analysis found that memory benefits appeared especially notable in adults aged roughly 66–76.
One particularly fascinating 2024 experiment gave sleep-deprived participants a single large dose of creatine and found improvements in cognitive performance along with measurable changes in cerebral energy metabolism.
Even more relevant to Nicola's Alzheimer's interest, a small 2025 pilot study investigated 20 grams/day of creatine monohydrate for eight weeks in patients with Alzheimer's disease. The work demonstrated feasibility, increased brain creatine and produced encouraging exploratory cognitive findings. However, this was a small pilot rather than definitive proof of treatment or prevention.
A 2025 systematic review specifically examining people aged 55 and older concluded that the limited available evidence suggests creatine may benefit cognition, particularly memory and attention, but emphasized that better-quality clinical trials are still required.
This distinction is important.
Nicola is directionally on solid scientific ground about creatine and the brain, but the exact 15–20 g/day prescription is ahead of the evidence.
We know creatine participates in brain-energy metabolism. We know supplementation can affect brain creatine. We have increasingly good evidence for cognitive benefits under conditions such as aging, sleep deprivation and metabolic stress. What we do not yet have is strong evidence that healthy adults taking 15–20 grams every day for years will prevent Alzheimer's disease.
So saying that creatine “crosses the blood-brain barrier and therefore prevents cognitive decline” makes two very different statements. The first is biologically supported. The second has not yet been demonstrated in large, long-duration randomized prevention trials.
Nicola is therefore highlighting an exciting research area—but her high-dose recommendations should be understood as an extrapolation from emerging research rather than established Alzheimer's-prevention guidelines.
6. Omega-3s, Vitamin D and Nutrition
Nicola's preferred supplement discussion usually extends beyond creatine to omega-3 fatty acids, particularly EPA and DHA.
She argues that DHA is especially important to neuronal membranes and that maintaining adequate EPA/DHA status may contribute to cardiovascular and neurological health. She has discussed measuring the omega-3 index rather than simply assuming that taking a fish-oil capsule produces an adequate level.
This fits her larger concept that cardiovascular health and brain health are inseparable. Brain tissue depends enormously on vascular function; conditions that damage blood vessels—hypertension, smoking, diabetes, abnormal lipids and inactivity—also increase dementia risk. High LDL cholesterol and hypertension are among the modifiable dementia risk factors identified by the Lancet Commission.
Nicola also discusses vitamin D and magnesium. Here I would be more conservative than some of her public recommendations. Low vitamin D is associated with several poor health outcomes, but observational associations do not prove that taking large supplemental doses prevents dementia. Nicola herself has acknowledged when discussing vitamin D that some of the evidence she cites is correlational.
Her broader dietary position is less controversial: favor minimally processed foods, adequate protein, plants and foods containing omega-3 fats while limiting excessive ultra-processed food and alcohol. Her emphasis is generally on maintaining metabolic and vascular health rather than promoting one narrowly defined “brain diet.”
7. Alzheimer's Disease and Nicola's Larger Mission
Nicola increasingly describes her professional mission in terms of ending or preventing Alzheimer's disease. Her doctoral interests, public speaking, newsletter and podcast have moved substantially toward cognitive longevity and neurodegeneration.
One valuable part of her message is that people should begin thinking about brain aging decades before dementia symptoms appear.
That is important because the biological processes associated with Alzheimer's can develop gradually over many years. Waiting until serious memory impairment occurs leaves fewer opportunities to modify risk factors that accumulated during midlife.
Nicola therefore focuses attention on what a person can influence earlier: cardiovascular fitness, blood pressure, glucose control, lipids, strength, sleep, smoking, alcohol, social connection and nutrition.
In this respect, her message tracks closely with mainstream dementia-prevention research. What distinguishes her is the athletic framing:
Don't merely try to avoid disease.
Build a brain capable of performing well.
That converts dementia prevention from a defensive medical concept into a performance goal.
8. Science Communicator Versus Research Scientist
It is useful to understand Nicola's role accurately.
She is not primarily a laboratory neuroscientist with hundreds of experimental publications. Her peer-reviewed publication record is comparatively modest, although her 2024 resistance-training review directly addresses her central research interest.
Her larger impact comes from science translation.
Through The Neuro Experience, Neuro Athletics, newsletters, social media, coaching and public appearances, she takes scientific papers—often complicated studies of exercise, physiology, sleep or neurodegeneration—and converts them into recommendations ordinary people can understand. Her podcast continues to publish interviews with physicians, neuroscientists and health researchers.
That ability is genuinely valuable. Academic research often moves slowly into everyday behavior.
But there is an inherent danger in this style of science communication: translating a probabilistic study into an actionable protocol can make preliminary science sound more settled than it is.
Nicola sometimes does this.
Statements about precise creatine doses, particular supplement targets, red-light therapy, hyperbaric oxygen and other emerging interventions occasionally go beyond what large clinical trials presently establish. In a 2025 discussion, for example, she was enthusiastic about red and infrared light while simultaneously acknowledging that some of the relevant work was preclinical or applicable to specific medical situations rather than routine prevention.
Interestingly, Nicola is often willing to revise her positions when evidence changes. Her public reversal from recommending 5 grams of creatine to recommending substantially higher amounts is one example.
That willingness to change is scientifically healthy, although it also demonstrates why her specific protocols should not automatically be mistaken for medical consensus.
9. The Core of Nicola's Brain-Health Program
Stripped of podcasts, supplements, biomarkers and technology, Nicola's message is much simpler than it first appears.
Her hierarchy is essentially:
Build cardiovascular fitness. Build and retain muscle. Exercise consistently. Sleep well. Maintain good metabolic and vascular health. Eat high-quality food. Avoid smoking and excessive alcohol. Protect the head from injury. Remain cognitively and socially engaged. Then consider evidence-supported supplements such as creatine and omega-3s as additions rather than substitutes.
That framework aligns surprisingly closely with the broader dementia-prevention literature.
And that may be the most valuable aspect of her work.
The glamorous part of modern longevity medicine is advanced imaging, supplements, neurotechnology, blood biomarkers, infrared lights and elaborate optimization protocols.
The interventions with the deepest evidence remain much less glamorous: exercise, strength, vascular health, sleep, nutrition and avoiding harmful exposures.
Nicola is unusually effective at making those ordinary behaviors seem like sophisticated neurological interventions.
Overall Assessment
Louisa Nicola belongs to a new generation of health communicators who are trying to connect exercise science, neuroscience and preventive medicine.
Her greatest contribution is the argument that aging of the brain should not be considered separately from aging of the body. Strong legs, good cardiovascular capacity, healthy blood vessels, adequate sleep and good metabolic health are not merely signs of physical fitness; increasingly, research suggests they are associated with maintaining cognition and brain structure as we age. Her own published review on resistance training is directly within this field.
Her emphasis on Alzheimer's prevention is also fundamentally hopeful without being entirely fanciful. Modern evidence suggests that a remarkably large fraction of population-level dementia risk is associated with potentially modifiable factors.
Where I would place a caution sign is around the precision of some of her protocols. “Exercise protects the aging brain” rests on a substantial body of evidence. “Everyone needs 15–20 grams of creatine to saturate the brain” is much less established. “Creatine may help cognition, particularly when the brain is stressed, sleep deprived or aging” is presently a considerably stronger scientific statement than “20 grams prevents cognitive decline.”
Overall, I would characterize Nicola as a knowledgeable and unusually effective neuroscience translator whose central recommendations are largely evidence-based, while some of her newer supplement and longevity recommendations run somewhat ahead of clinical consensus.
Her most important lesson doesn't require buying anything:
Train your body if you want to preserve your brain.
And increasingly, the neuroscience literature suggests she has picked a very good hill to stand on.
Neurophysiology, Brain Performance, Exercise, and Alzheimer’s Prevention
1. Who Is Louisa Nicola?
Louisa Nicola is an Australian-born clinical neurophysiologist, human-performance coach, researcher, entrepreneur, and science communicator whose work focuses on protecting and improving the human brain. She is the founder of Neuro Athletics, a consulting and education company that applies neuroscience to cognitive performance, athletic performance, healthy aging, and the prevention of neurological disease. She is also the host of The Neuro Experience, a long-running podcast devoted to neuroscience, health, longevity, sleep, exercise, and human performance.
Nicola is particularly interesting because she occupies the intersection of two worlds that historically have not always been closely connected: exercise physiology and neuroscience. Rather than treating the brain as something that is primarily protected by crossword puzzles, medications, or intellectual activity, she argues that the brain is profoundly affected by what happens to the rest of the body. Muscle strength, cardiorespiratory fitness, blood pressure, metabolic health, sleep, diet and physical activity therefore become brain-health interventions as well as general health interventions.
Her current professional biography lists her as MMed, PhD(c). She holds a Master of Medicine in Clinical Neurophysiology from the University of Sydney and is pursuing doctoral research focused on neuroscience and Alzheimer's disease. Current biographical material describes her doctoral work as examining the effects of exercise, particularly resistance exercise, on the aging brain.
That credential distinction is worth making. Nicola is frequently called “Dr. Louisa Nicola” on podcasts and health websites, but the more precise description, based on her current professional biography, is clinical neurophysiologist and PhD candidate rather than medical doctor/physician. Her MMed is a postgraduate academic degree; it should not be confused automatically with an MD.
Before entering neuroscience, Nicola was a high-level triathlete who competed internationally for Australia. She has described a serious cycling accident as helping redirect her career toward medicine, neuroscience and understanding human performance. That athletic background remains central to her approach: she tends to think of the brain as an organ that can be trained, stressed, recovered and protected, much as an athlete approaches muscle and cardiovascular fitness.
2. Neuro Athletics and Her Central Philosophy
Nicola founded Neuro Athletics to apply neuroscience techniques to athletes, executives and other people working in high-pressure environments. Her clients have reportedly included professional athletes from the NBA, NFL and MLB as well as executives and finance professionals. Her approach has incorporated cognitive testing, laboratory measurements and EEG-based assessments in an attempt to understand an individual's neurological and physiological performance.
The central idea behind Neuro Athletics is surprisingly straightforward:
You cannot separate brain health from physical health.
Nicola therefore places far more emphasis on exercise, sleep and cardiovascular/metabolic health than on exotic “brain-training” products. Earlier in her career she frequently described three major pillars—sleep, exercise and nutrition—and those remain at the center of her recommendations.
Her philosophy has gradually expanded from optimizing elite performance to something much larger: extending cognitive health throughout aging and reducing the probability of Alzheimer’s disease and other dementias. Her recent public work increasingly emphasizes Alzheimer's prevention, particularly in middle-aged and older adults.
This is where Nicola's message resonates with modern dementia research. The 2024 Lancet Commission estimated that approximately 45% of dementia cases could potentially be prevented or delayed by addressing 14 modifiable risk factors across the lifespan. These include inadequate education, hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, excessive alcohol consumption, social isolation, air pollution and untreated vision loss.
Nicola sometimes describes Alzheimer's rather strongly as a “lifestyle-driven disease.” That wording goes farther than I would. Alzheimer's is a complex neurodegenerative disease involving aging, genetics, amyloid and tau pathology, vascular health, metabolic factors, inflammation and environmental exposures. Lifestyle can substantially modify risk, but a person cannot guarantee prevention simply by living correctly. The Alzheimer's Association likewise describes exercise and healthy eating as strategies that may lower risk, rather than claiming that Alzheimer's can currently be reliably prevented.
So the stronger scientific translation of Nicola's message is:
A very substantial fraction of dementia risk appears modifiable, even though Alzheimer's itself cannot presently be considered completely preventable.
3. Exercise: Probably the Strongest Part of Nicola's Message
If one idea dominates Nicola's work, it is that exercise is medicine for the brain.
She emphasizes both aerobic conditioning and resistance training but has become especially interested in muscle strength and resistance exercise. Her reasoning is that skeletal muscle is not merely mechanical tissue. Contracting muscle affects metabolism, cardiovascular function, insulin sensitivity and signaling molecules that can influence the nervous system.
Nicola coauthored a 2024 scientific narrative review titled “Does resistance training in older adults lead to structural brain changes associated with a lower risk of Alzheimer's dementia?” The authors concluded that preliminary research indicates resistance exercise can produce structural brain changes that may reduce Alzheimer's risk or slow processes associated with progression, while also emphasizing that the research remains incomplete.
Subsequent clinical evidence makes the idea even more interesting. A 2025 randomized study of older adults with mild cognitive impairment found that 24 weeks of resistance training improved verbal episodic memory, produced favorable changes in white-matter integrity, and appeared to protect portions of the hippocampus and precuneus from atrophy compared with controls. Those brain regions are important because they are affected during cognitive aging and Alzheimer's disease.
There is also compelling long-term observational evidence. Nicola frequently discusses a study involving female twins in which greater leg power predicted better cognitive aging and global brain structure roughly a decade later. The original research found that leg power was associated with subsequent cognition and brain structure even after accounting for shared genetics and early-life environment.
This doesn't mean doing squats will guarantee that someone avoids dementia. It means something more defensible: maintaining muscular strength appears to be one marker—and possibly one contributor—to healthier brain aging.
Nicola favors compound movements such as squats and deadlifts because they efficiently train large amounts of muscle. She also advocates aerobic exercise, higher-intensity cardiovascular work and regular daily movement rather than relying exclusively on strength training. In public discussions she has repeatedly presented exercise as the intervention she would put ahead of most supplements or expensive longevity technologies.
That priority is well supported. Higher levels of physical activity in middle and later life have repeatedly been associated with lower incidence of dementia, and randomized exercise studies increasingly demonstrate measurable effects on cognition and brain structure.
4. Sleep and Brain Recovery
The second pillar of Nicola's philosophy is sleep.
Her argument is broader than “sleep makes you feel rested.” Sleep affects memory consolidation, emotional regulation, metabolic function, hormonal signaling and the ability of the brain to maintain normal cellular function.
Nicola frequently emphasizes maintaining a regular sleep schedule, obtaining sufficient sleep and reducing behaviors that interfere with deep and restorative sleep. Her Neuro Athletics material has discussed sleep extensively since the early years of the company.
The relationship between sleep and dementia is scientifically intriguing but complicated. Poor sleep is associated with worse cognitive outcomes, while neurological disease itself can disrupt sleep. Consequently, cause and effect can run in both directions. It would therefore be too strong to say that simply sleeping eight hours prevents Alzheimer's.
The practical lesson is nevertheless sound. Treat sleep as a core component of brain health rather than disposable downtime.
Nicola's performance background also influences this thinking. To an athlete, recovery is part of training rather than the absence of training. She applies essentially the same principle to the nervous system: chronic stress combined with insufficient recovery eventually degrades performance.
5. Creatine: Nicola's Most Interesting—and Most Debatable—Recommendation
Creatine has become one of Nicola's most prominent subjects.
Creatine is best known as a sports supplement. Muscle cells use the creatine-phosphocreatine system to rapidly regenerate ATP, the cellular energy currency required during high-energy demand. The brain also contains creatine and uses the phosphocreatine system for energy buffering.
Nicola formerly recommended approximately 5 grams of creatine monohydrate per day, which is the conventional maintenance dose used for muscle performance. She later publicly revised that recommendation upward. In a 2025 interview she argued that 10 grams should be viewed as a starting point for brain effects, roughly 12–15 grams for many women, and as much as 15–20 grams per day for some men or people experiencing neurological stress.
She has explained the idea by saying that larger supplemental amounts are required to substantially increase creatine availability in the brain because brain creatine concentrations are more resistant to change than muscle creatine concentrations.
There is real science behind her enthusiasm.
A 2024 systematic review and meta-analysis of randomized controlled trials found evidence that creatine supplementation may improve some aspects of memory, attention and information-processing speed in adults, although the results were not universally positive.
A separate meta-analysis found that memory benefits appeared especially notable in adults aged roughly 66–76.
One particularly fascinating 2024 experiment gave sleep-deprived participants a single large dose of creatine and found improvements in cognitive performance along with measurable changes in cerebral energy metabolism.
Even more relevant to Nicola's Alzheimer's interest, a small 2025 pilot study investigated 20 grams/day of creatine monohydrate for eight weeks in patients with Alzheimer's disease. The work demonstrated feasibility, increased brain creatine and produced encouraging exploratory cognitive findings. However, this was a small pilot rather than definitive proof of treatment or prevention.
A 2025 systematic review specifically examining people aged 55 and older concluded that the limited available evidence suggests creatine may benefit cognition, particularly memory and attention, but emphasized that better-quality clinical trials are still required.
This distinction is important.
Nicola is directionally on solid scientific ground about creatine and the brain, but the exact 15–20 g/day prescription is ahead of the evidence.
We know creatine participates in brain-energy metabolism. We know supplementation can affect brain creatine. We have increasingly good evidence for cognitive benefits under conditions such as aging, sleep deprivation and metabolic stress. What we do not yet have is strong evidence that healthy adults taking 15–20 grams every day for years will prevent Alzheimer's disease.
So saying that creatine “crosses the blood-brain barrier and therefore prevents cognitive decline” makes two very different statements. The first is biologically supported. The second has not yet been demonstrated in large, long-duration randomized prevention trials.
Nicola is therefore highlighting an exciting research area—but her high-dose recommendations should be understood as an extrapolation from emerging research rather than established Alzheimer's-prevention guidelines.
6. Omega-3s, Vitamin D and Nutrition
Nicola's preferred supplement discussion usually extends beyond creatine to omega-3 fatty acids, particularly EPA and DHA.
She argues that DHA is especially important to neuronal membranes and that maintaining adequate EPA/DHA status may contribute to cardiovascular and neurological health. She has discussed measuring the omega-3 index rather than simply assuming that taking a fish-oil capsule produces an adequate level.
This fits her larger concept that cardiovascular health and brain health are inseparable. Brain tissue depends enormously on vascular function; conditions that damage blood vessels—hypertension, smoking, diabetes, abnormal lipids and inactivity—also increase dementia risk. High LDL cholesterol and hypertension are among the modifiable dementia risk factors identified by the Lancet Commission.
Nicola also discusses vitamin D and magnesium. Here I would be more conservative than some of her public recommendations. Low vitamin D is associated with several poor health outcomes, but observational associations do not prove that taking large supplemental doses prevents dementia. Nicola herself has acknowledged when discussing vitamin D that some of the evidence she cites is correlational.
Her broader dietary position is less controversial: favor minimally processed foods, adequate protein, plants and foods containing omega-3 fats while limiting excessive ultra-processed food and alcohol. Her emphasis is generally on maintaining metabolic and vascular health rather than promoting one narrowly defined “brain diet.”
7. Alzheimer's Disease and Nicola's Larger Mission
Nicola increasingly describes her professional mission in terms of ending or preventing Alzheimer's disease. Her doctoral interests, public speaking, newsletter and podcast have moved substantially toward cognitive longevity and neurodegeneration.
One valuable part of her message is that people should begin thinking about brain aging decades before dementia symptoms appear.
That is important because the biological processes associated with Alzheimer's can develop gradually over many years. Waiting until serious memory impairment occurs leaves fewer opportunities to modify risk factors that accumulated during midlife.
Nicola therefore focuses attention on what a person can influence earlier: cardiovascular fitness, blood pressure, glucose control, lipids, strength, sleep, smoking, alcohol, social connection and nutrition.
In this respect, her message tracks closely with mainstream dementia-prevention research. What distinguishes her is the athletic framing:
Don't merely try to avoid disease.
Build a brain capable of performing well.
That converts dementia prevention from a defensive medical concept into a performance goal.
8. Science Communicator Versus Research Scientist
It is useful to understand Nicola's role accurately.
She is not primarily a laboratory neuroscientist with hundreds of experimental publications. Her peer-reviewed publication record is comparatively modest, although her 2024 resistance-training review directly addresses her central research interest.
Her larger impact comes from science translation.
Through The Neuro Experience, Neuro Athletics, newsletters, social media, coaching and public appearances, she takes scientific papers—often complicated studies of exercise, physiology, sleep or neurodegeneration—and converts them into recommendations ordinary people can understand. Her podcast continues to publish interviews with physicians, neuroscientists and health researchers.
That ability is genuinely valuable. Academic research often moves slowly into everyday behavior.
But there is an inherent danger in this style of science communication: translating a probabilistic study into an actionable protocol can make preliminary science sound more settled than it is.
Nicola sometimes does this.
Statements about precise creatine doses, particular supplement targets, red-light therapy, hyperbaric oxygen and other emerging interventions occasionally go beyond what large clinical trials presently establish. In a 2025 discussion, for example, she was enthusiastic about red and infrared light while simultaneously acknowledging that some of the relevant work was preclinical or applicable to specific medical situations rather than routine prevention.
Interestingly, Nicola is often willing to revise her positions when evidence changes. Her public reversal from recommending 5 grams of creatine to recommending substantially higher amounts is one example.
That willingness to change is scientifically healthy, although it also demonstrates why her specific protocols should not automatically be mistaken for medical consensus.
9. The Core of Nicola's Brain-Health Program
Stripped of podcasts, supplements, biomarkers and technology, Nicola's message is much simpler than it first appears.
Her hierarchy is essentially:
Build cardiovascular fitness. Build and retain muscle. Exercise consistently. Sleep well. Maintain good metabolic and vascular health. Eat high-quality food. Avoid smoking and excessive alcohol. Protect the head from injury. Remain cognitively and socially engaged. Then consider evidence-supported supplements such as creatine and omega-3s as additions rather than substitutes.
That framework aligns surprisingly closely with the broader dementia-prevention literature.
And that may be the most valuable aspect of her work.
The glamorous part of modern longevity medicine is advanced imaging, supplements, neurotechnology, blood biomarkers, infrared lights and elaborate optimization protocols.
The interventions with the deepest evidence remain much less glamorous: exercise, strength, vascular health, sleep, nutrition and avoiding harmful exposures.
Nicola is unusually effective at making those ordinary behaviors seem like sophisticated neurological interventions.
Overall Assessment
Louisa Nicola belongs to a new generation of health communicators who are trying to connect exercise science, neuroscience and preventive medicine.
Her greatest contribution is the argument that aging of the brain should not be considered separately from aging of the body. Strong legs, good cardiovascular capacity, healthy blood vessels, adequate sleep and good metabolic health are not merely signs of physical fitness; increasingly, research suggests they are associated with maintaining cognition and brain structure as we age. Her own published review on resistance training is directly within this field.
Her emphasis on Alzheimer's prevention is also fundamentally hopeful without being entirely fanciful. Modern evidence suggests that a remarkably large fraction of population-level dementia risk is associated with potentially modifiable factors.
Where I would place a caution sign is around the precision of some of her protocols. “Exercise protects the aging brain” rests on a substantial body of evidence. “Everyone needs 15–20 grams of creatine to saturate the brain” is much less established. “Creatine may help cognition, particularly when the brain is stressed, sleep deprived or aging” is presently a considerably stronger scientific statement than “20 grams prevents cognitive decline.”
Overall, I would characterize Nicola as a knowledgeable and unusually effective neuroscience translator whose central recommendations are largely evidence-based, while some of her newer supplement and longevity recommendations run somewhat ahead of clinical consensus.
Her most important lesson doesn't require buying anything:
Train your body if you want to preserve your brain.
And increasingly, the neuroscience literature suggests she has picked a very good hill to stand on.
Here are eight worthwhile long-form Louisa Nicola interviews/videos, weighted toward brain health, exercise, dementia prevention, sleep, and creatine:
- How Creatine, Omega-3, Vitamin D and Specific Exercises Can Protect Your Brain — Sept. 3, 2025 | The Doctor’s Kitchen, Dr. Rupy Aujla
YouTube: https://www.youtube.com/watch?v=4oui6X7WywU
Summary: Probably the best single interview for her current thinking on higher-dose creatine, omega-3s, vitamin D, resistance training, and dementia prevention. - How to Protect & Enhance Your Brain Health — Feb. 12, 2025 | Feel Better, Live More, Dr. Rangan Chatterjee #522
YouTube: https://www.youtube.com/watch?v=P-s3UTa_qlQ
Summary: A broad discussion of Alzheimer's risk, aerobic and resistance exercise, sleep, nutrition, creatine, and practical habits intended to preserve cognition with age. - Louisa Nicola — Human Performance — Oct. 22, 2024 | Dr. Vonda Wright, HFYH #102
YouTube: https://www.youtube.com/watch?v=fOCiDZ22lFo
Summary: Especially useful on resistance training, BDNF, neuroplasticity, sleep, menopause, muscle and maintaining cognitive reserve as we age. - Boosting Cognitive Function Through Fitness — Sept. 10, 2024 | The Dr. Gabrielle Lyon Show
YouTube: https://www.youtube.com/watch?v=o2XAaBa6klg
Summary: A particularly strong exercise-focused episode explaining how resistance training, cardiovascular fitness, muscle-derived myokines and metabolic health may affect Alzheimer's risk and cognitive aging. - Louisa Nicola on Optimizing Brain Health — May 1, 2024 | Muscle for Life, Mike Matthews #1147
YouTube: https://www.youtube.com/watch?v=3gl_TRhVl48
Summary: A practical overview of lifestyle strategies for maintaining cognition and reducing age-related brain decline, with considerable attention to exercise and everyday behavior. - How to Keep Your Brain Young and Healthy — May 11, 2023 | The Dr. Gabrielle Lyon Show
YouTube: https://www.youtube.com/watch?v=WtKHxrz-seA
Summary: An earlier but excellent overview of Nicola's three major pillars--sleep, exercise and nutrition—plus Alzheimer's prevention, supplements and strength training for brain health. - STOP Brain Degeneration With These Tools — Jan. 12, 2023 | Mark Bell’s Power Project #868
YouTube: https://www.youtube.com/watch?v=zMeuBkZUsbM
Summary: A long, conversational treatment of exercise as a neurological intervention, along with sleep, cognitive decline, nutrition and practical brain-performance strategies. - How to Maximise Your Brain’s Performance — Jan. 22, 2022 | Modern Wisdom with Chris Williamson #425
YouTube: https://www.youtube.com/watch?v=y1vnIzo4jik
Summary: One of Nicola's best early interviews, covering brain-performance training, sleep, supplements, cognitive function, stress management and the protocols she used with elite performers. - Louisa Nicola – Neurophysiologist Warns About the Hidden Dangers of Black-Market Peptides | SRS #300 — April 30, 2026 | The Shawn Ryan Show
YouTube: https://www.youtube.com/watch?v=y4ATx9A9y6w
Length: ~3 hours 5 minutes
Summary: A wide-ranging deep dive into Alzheimer’s and cognitive decline, peptides and their risks, cancer, exercise and BDNF, cardiovascular and metabolic health, sleep, inflammation, supplements, and Nicola’s overall strategy for maintaining brain health throughout life. The official episode description also emphasizes early cognitive baseline testing, strength and aerobic training, women’s Alzheimer’s risk, and treating brain health proactively rather than waiting for symptoms.
Detailed Summary — Louisa Nicola on The Shawn Ryan Show #300Episode: Louisa Nicola – Peptides, Cancer and the Deadly Habits That Lead to Alzheimer’s
Published: April 30, 2026
Length: about 3 hours 5 minutes.
The central theme of the interview is Nicola’s argument that the brain should be treated like the rest of the body: something that can be trained, protected, stressed, damaged, and—in many respects—made more resilient. Alzheimer's disease dominates the conversation, but Ryan and Nicola range widely through exercise, sleep, creatine, cholesterol, GLP-1 drugs, menopause, peptides, vaccines, psychedelics, cannabis, traumatic brain injury, social isolation, omega-3s, and emerging neuroscience.
One important caution before getting into her recommendations: Nicola frequently moves from established evidence to plausible mechanisms to personal interpretation without always sharply separating them. Her core message—exercise, control cardiovascular risk, sleep adequately, stay socially and cognitively engaged—is strongly aligned with mainstream dementia-prevention research. Some of her numerical claims and more experimental recommendations are substantially more aggressive.
1. Why Alzheimer's is the centerpiece
Shawn Ryan begins by explaining that Alzheimer's and cancer are two of his greatest health fears and that his grandfather died with Alzheimer's. Nicola responds by emphasizing the enormous and growing burden of dementia and arguing that people make a mistake when they think of Alzheimer's as something that suddenly begins in their seventies or eighties.
Her central concept is that late-life cognitive disease often represents processes occurring for decades before obvious symptoms appear. Therefore, the important period for prevention isn't simply age 70—it is one's 30s, 40s, 50s and 60s.
This leads to perhaps the strongest theme of the entire interview:
Don't wait for memory loss before taking brain health seriously.
She wants people to think about Alzheimer's much as modern medicine thinks about cardiovascular disease: control the underlying risk factors many years before the catastrophic event occurs.
2. Her strongest—and most controversial—claim: Alzheimer's is largely preventable
Nicola tells Ryan that roughly 95% of Alzheimer's cases are lifestyle-driven, contrasting them with a small percentage she attributes primarily to genetics. She uses this to argue that most people have considerable agency over whether they eventually develop the disease.
This is one of the places where I would not take her number literally.
The highly regarded 2024 Lancet Commission concluded that approximately 45% of dementia cases might potentially be prevented or delayed by addressing 14 modifiable risk factors—not 95%. Those risk factors include hypertension, high LDL cholesterol, diabetes, obesity, smoking, physical inactivity, excessive alcohol, hearing loss, untreated vision loss, depression, social isolation and traumatic brain injury.
So her underlying message is well supported:
A remarkably large portion of dementia risk is modifiable.
But saying that 95% of Alzheimer's is essentially a lifestyle choice goes considerably beyond current scientific consensus.
3. Genetics and APOE4
Nicola explains the difference between deterministic genetic mutations and risk genes.
She discusses the rare mutations involving APP, PSEN1 and PSEN2, which can produce familial early-onset Alzheimer's, and contrasts these with APOE4, which greatly increases risk but does not guarantee disease. She notes that inheriting one APOE4 allele raises risk and inheriting two raises it substantially more. Her broader point is that having APOE4 should be viewed as a warning to manage modifiable risks aggressively rather than as a prediction that Alzheimer's is inevitable.
That is an important distinction:
Risk ≠ destiny.
Someone with high genetic susceptibility may never develop dementia, while someone without APOE4 may.
4. Amyloid, tau and what Alzheimer's actually does to the brain
Nicola uses a physical brain model during the interview and gives Ryan a simplified neuroanatomy lesson.
She describes neurons as somewhat like trees:
Amyloid-beta accumulates predominantly outside neurons.
Tau becomes abnormal inside neurons.
As these processes progress, synapses fail, neurons become dysfunctional or die, networks lose connectivity, and brain regions important for memory and executive function deteriorate.
She places special emphasis on the hippocampus, an area critical for forming new memories, explaining why short-term and recent memory can become impaired early while very old memories sometimes remain accessible much longer.
5. Nicola challenges a simplistic version of the amyloid hypothesis
One of the more interesting portions of the interview concerns amyloid.
Nicola argues that amyloid-beta isn't simply "garbage" the body mistakenly creates. She describes it as an antimicrobial peptide that may have defensive functions and proposes that inflammation, infection and other forms of physiological stress may stimulate amyloid production.
Her larger question is therefore:
Instead of asking only how we remove amyloid plaques, shouldn't we also ask why amyloid is being produced and accumulating?
This is a legitimate and active area of Alzheimer's research. However, Nicola sometimes talks as though the infection/inflammation explanation has essentially replaced the amyloid hypothesis. It hasn't. Pathogens and immune activation are increasingly studied as possible contributors, but their precise role in Alzheimer's remains unresolved. A 2025 Nature review described the infectious hypothesis as increasingly plausible but still inconclusive.
So this is one of the episode's fascinating areas where the science is developing rather than settled.
6. Cognitive reserve: build a bigger brain "safety margin"
Nicola introduces the concept of cognitive reserve.
The idea is that two people can have similar biological brain pathology yet exhibit very different levels of impairment because one brain has developed more robust neural networks and alternative pathways.
She encourages lifelong:
reading, learning, problem-solving, social interaction, new experiences, intellectually difficult activities and exercise.
She is especially concerned about people becoming cognitively passive after retirement. Her message isn't that retirement itself biologically causes Alzheimer's, but that retirement can remove several protective behaviors simultaneously—daily problem-solving, movement, social interaction, purpose and intellectual stimulation.
That fits well with the broader evidence linking social isolation and reduced cognitive engagement with dementia risk.
7. AI and "brain rot"
Ryan asks whether heavy dependence on AI could impair cognition.
Nicola worries that people are outsourcing mental work—calculations, remembering information, forming arguments, solving problems—and combines this with concerns about endless low-quality social-media scrolling. She compares the brain with muscle: abilities that aren't exercised tend to deteriorate.
She even admits that she once routinely performed mathematics mentally but now catches herself using ChatGPT for calculations she formerly would have done herself.
Where she gets ahead of the evidence is when she suggests this could lead directly toward mild cognitive impairment and ultimately Alzheimer's.
There is not presently evidence establishing that normal use of AI causes Alzheimer's disease.
The useful version of her point is simpler: don't outsource all thinking. Continue reading, calculating, writing, remembering, learning and solving difficult problems.
8. Head trauma, military service and CTE
Because Ryan is a veteran, they spend considerable time discussing traumatic brain injuries.
Nicola emphasizes repeated concussions and TBIs as important long-term neurological risks, mentioning chronic traumatic encephalopathy (CTE) and the cumulative consequences of repeated brain trauma.
She stresses the importance of the period immediately following a concussion and argues strongly for properly managed concussion protocols.
She also broadens the subject beyond obvious head injuries to include hearing damage from explosions and chronic exposure to operational stress.
One particularly useful point is her emphasis on hearing loss. If hearing deteriorates, the brain receives less auditory stimulation, social interaction can decline, and cognitive workload changes. Hearing loss is indeed among the established modifiable dementia risk factors.
9. Women, menopause and Alzheimer's
Nicola devotes a substantial section to the disproportionately high prevalence of Alzheimer's among women.
She points to two broad explanations.
First, women generally live longer, and age is the largest Alzheimer's risk factor.
Second, she emphasizes the neurological importance of estrogen. Rather than thinking of estrogen merely as a reproductive hormone, she describes it as an important neuroendocrine signal involved in brain metabolism, neuronal function and other systems.
She argues that the menopausal transition therefore represents an important period during which women should pay especially close attention to sleep, exercise, muscle, cardiovascular health and metabolic health.
Nicola is generally favorable toward appropriately prescribed menopausal hormone therapy, but makes an interesting distinction: she doesn't present hormone therapy as a magic Alzheimer's drug. Rather, she says reducing hot flashes, sleep disruption, mood changes and loss of muscle may make it easier for women to perform the behaviors that support long-term brain health.
That is a much more nuanced argument than saying "estrogen prevents Alzheimer's."
10. The 14 modifiable dementia risk factors
At roughly 1:50 into the program, Nicola specifically invokes the Lancet dementia work.
Among the things she emphasizes are:
high blood pressure, obesity, type 2 diabetes, smoking, excessive alcohol use, inactivity, high cholesterol, social isolation, hearing loss, vision problems and head injury.
Her practical message is very strong:
A person worried about dementia should spend at least as much attention on blood pressure, LDL/ApoB, glucose, weight, activity and hearing as on exotic "brain supplements."
This may be the most important clinical takeaway from the entire three-hour interview.
11. Exercise is Nicola's number-one brain intervention
This is the heart of her professional work.
Nicola divides exercise into roughly three categories:
Aerobic exercise
High-intensity/VO2-max work
Resistance training
She also includes what she calls neurocognitive or "neuroathletic" training.
She considers exercise the single most powerful readily available intervention because it affects cardiovascular health, insulin sensitivity, body composition, inflammation, mitochondrial function, muscle signaling and brain biology simultaneously.
Nicola's own published research has focused on resistance exercise and brain structure in older adults. Her 2024 review concluded that preliminary evidence suggests resistance exercise can produce structural brain changes associated with lower Alzheimer's risk or slower progression, while acknowledging that better trials are needed.
12. BDNF: "fertilizer for the brain"
Nicola frequently discusses brain-derived neurotrophic factor (BDNF).
BDNF supports neuronal survival, synaptic plasticity and the brain's ability to adapt and form new connections.
She argues that aerobic exercise substantially increases BDNF signaling and therefore helps maintain the brain's ability to remodel itself. Later, when discussing psychedelics, she returns to BDNF as one possible pathway by which certain treatments could alter neural networks.
Her broad analogy is memorable:
Exercise sends a biological signal to the brain saying, "Remain adaptable."
13. High-intensity exercise and lactate
Nicola is particularly enthusiastic about occasional vigorous exercise.
At very high intensities—around Zone 5—the body relies heavily on glycolysis and produces lactate. Contrary to the old idea that lactate is merely metabolic waste, she explains that lactate can serve as an important fuel and signaling molecule, including for the brain.
She therefore sees VO2-max training as having neurological benefits beyond simply strengthening the heart.
She also discusses emerging exercise oncology research and suggests high-intensity exercise may help inhibit tumor progression through several mechanisms. That field is real and exciting, but some of her explanations—such as exercise straightforwardly "clearing circulating tumor cells"—should be regarded as mechanistic interpretations rather than a reason to think vigorous exercise independently treats cancer.
14. Why she cares so much about resistance training
Resistance training receives almost equal billing.
When skeletal muscle contracts strongly, it releases signaling molecules known as myokines. Nicola describes these as biological "care packages" traveling through the bloodstream and influencing the brain, liver, cardiovascular system and other tissues.
She links resistance exercise to:
better insulin sensitivity, improved metabolism, preserved muscle, mitochondrial health, neuroplasticity, healthier aging and possibly reduced neurodegenerative risk.
Her bottom-line recommendation in the interview is at least two resistance-training sessions per week, combined with aerobic exercise and some higher-intensity cardiovascular work.
15. GLP-1 drugs: Nicola is extremely enthusiastic
Nicola calls GLP-1-based medications "remarkable."
She discusses drugs such as semaglutide and tirzepatide and the emerging triple-agonist retatrutide. She thinks their importance goes beyond weight loss because obesity, diabetes and metabolic dysfunction themselves contribute to dementia risk. She also points to reports that GLP-1 therapy can reduce alcohol craving in some people.
Her reasoning is:
If a medication dramatically reduces obesity, insulin resistance and diabetes, it may indirectly improve long-term brain health even if the medication itself isn't an Alzheimer's drug.
Importantly, she acknowledges that simply demonstrating a GLP-1 drug directly prevents dementia has been much harder.
16. Peptides—and why she strongly opposes black-market BPC-157
This is another major section of the episode.
Nicola distinguishes approved peptide drugs from gray-market experimental peptides.
Insulin and GLP-1 drugs are peptides, but they have gone through human clinical trials, manufacturing controls and regulatory review.
BPC-157 is completely different.
She is highly critical of people purchasing BPC-157 from gray- or black-market sources and injecting it for tendon or joint injuries. Her concern isn't simply that it might not work; she worries that users may not know precisely what they are injecting or its long-term effects.
She particularly worries about claims that BPC-157 encourages angiogenesis—the formation of blood vessels. Her concern is theoretical: if something stimulates new vasculature around injured tissue, what would happen if an undetected tumor were also present?
She does not demonstrate in the interview that BPC-157 causes cancer. Her argument is instead:
We don't have enough high-quality human safety data to know that it doesn't create unacceptable risks.
That is a much more accurate way to understand this segment.
She predicts peptides will become increasingly important in medicine but wants them tested and regulated rather than bought online.
17. Shingles vaccination and dementia
This was one of the most striking portions of the episode.
Nicola says shingles vaccination after age 50 may substantially reduce dementia risk and urges older adults to get vaccinated. She explains that varicella-zoster virus remains dormant after chickenpox and can reactivate later as shingles, generating inflammation and potentially interacting with neurological disease.
The underlying research here is genuinely interesting, although she overstates the size of the best-established effect.
She says the reduction may be around 50%. A major 2025 natural experiment published in Nature found approximately a 20% relative reduction in new dementia diagnoses over seven years among people who actually received the older shingles vaccine. Other studies of recombinant Shingrix have also found lower dementia incidence, but randomized dementia-prevention trials have not yet proven that shingles vaccination itself prevents Alzheimer's.
So:
Nicola's direction is supported; the 50% number is too strong as a general claim.
18. Vaccines more broadly
Ryan asks Nicola directly whether she is anti-vaccine.
She says no, emphasizing the enormous historical impact of vaccination against infectious disease. She discusses polio, smallpox, HPV and shingles and expresses concern about broad anti-vaccine sentiment following the COVID era.
She nevertheless says she doesn't believe people should receive vaccinations indiscriminately when they aren't indicated and distinguishes her support for initial COVID vaccination during the pandemic from her views about repeated later boosters.
This section becomes political for a while, including disagreement with RFK Jr. over vaccine policy and discussion of environmental chemicals associated with neurological disease.
19. Cholesterol, LDL/ApoB, statins and brain vascular health
Nicola strongly rejects the idea that keeping LDL cholesterol high is somehow good for the aging brain.
She explains that the brain depends on a healthy vascular system and that cardiovascular disease and cerebrovascular disease share many risk factors. She therefore emphasizes controlling LDL cholesterol and ApoB, particularly in people with cardiovascular risk.
She is generally supportive of statins when medically indicated and rejects claims that statins broadly cause dementia.
This connects to one of her biggest conceptual points: What is good for the arteries is usually good for the brain.
Hypertension, atherosclerosis, stroke, diabetes and vascular injury aren't merely "heart problems." They directly influence cognitive aging.
20. Psychedelics and ibogaine
Ryan discusses his personal experience with ibogaine and reports feeling cognitively sharper afterward.
Nicola finds psychedelic research promising, particularly for PTSD and severe depression, but she is considerably more cautious here than she is about exercise or creatine.
She speculates that neuroplasticity and BDNF might explain some reported benefits, but repeatedly acknowledges that she doesn't fully understand the mechanisms.
She is concerned about the possibility of triggering:
psychosis, schizophrenia-like symptoms or prolonged abnormal mental states in susceptible individuals.
Her position is essentially:
Potentially powerful therapeutic tool—especially in carefully controlled settings—but not something to casually self-administer.
She does not regard psychedelics as a cure for Alzheimer's, although she speculates that future therapeutic "cocktails" might indirectly reduce dementia risk by treating depression, PTSD and other risk factors.
21. Creatine: one of the most important segmentsNear the end
Ryan asks directly:
"So people should be taking creatine?"
Nicola answers yes.
She argues that creatine isn't merely a muscle supplement; the brain also uses the creatine-phosphocreatine system to regenerate ATP.
She says research suggests roughly 10–12 grams/day can raise brain creatine, and discusses larger amounts during neurological stress.
She highlights a particularly intriguing 2025 study in which 20 Alzheimer's patients took 20 g/day of creatine monohydrate for eight weeks. The study reported increased brain creatine and encouraging cognitive findings.
This study really does exist.
But there is a major limitation Nicola doesn't emphasize enough:
It was a small, single-arm pilot trial—not a randomized placebo-controlled demonstration that creatine treats Alzheimer's.So it is promising evidence, not proof.
Her argument that the brain needs larger amounts of creatine than muscle to meaningfully raise cerebral creatine levels is biologically plausible and increasingly studied. Her leap from that evidence to recommending high chronic doses for everyone is more speculative.
22. Creatine and sleep deprivation
Nicola also discusses research showing that a large dose of creatine can improve cognitive performance during acute sleep deprivation.
She goes so far as to say a ~15-g bolus can almost compensate cognitively for a bad night's sleep.
That's an intriguing experimental finding, but it does not mean creatine replaces sleep.
The sensible interpretation is that improving cerebral energy availability may partly preserve cognition under metabolic stress.
23. Sleep is non-negotiable
Sleep is one of Nicola's major pillars.
She describes deep sleep as a period of restoration and waste clearance and advocates approximately 7½ hours of sleep nightly. She recommends lowering household lighting in the evening and personally favors dim or red illumination before bed to facilitate the transition into sleep.
She repeatedly links inadequate sleep with:
impaired cognition, metabolic dysfunction, elevated stress signaling and potentially impaired clearance of proteins associated with neurodegeneration.
Whatever one thinks of the details of the amyloid mechanism, her overall conclusion is very well grounded:
Chronic inadequate sleep is bad for cognitive and cardiovascular health.
24. Marijuana
Nicola is considerably more negative about THC.
She argues that people often mistake sedation for high-quality sleep and says marijuana may interfere with normal sleep architecture, particularly REM and deep sleep. She also points to the risk of psychosis with heavy cannabis exposure in susceptible people.
She distinguishes THC from CBD, noting CBD's established medical use in certain epilepsy syndromes.
Her description of marijuana as simply "terrible" is broader than the scientific evidence warrants, but the distinction between feeling sedated and achieving normal restorative sleep is an important one.
25. Omega-3s
At the end of the interview, Nicola strongly recommends EPA and DHA.
She stresses the large amount of lipid in the nervous system and the importance of DHA to neuronal membranes. She also cautions that poor-quality fish-oil supplements can become oxidized.
She gives a very aggressive intake recommendation—approximately 2 g DHA plus 2 g EPA daily.
That is not a universal clinical guideline for preventing Alzheimer's and is substantially more than many people consume through standard supplements. Someone contemplating that dose, particularly while using anticoagulant or antiplatelet drugs, should treat it as something to discuss with a clinician rather than simply adopting Nicola's dose.
26. Nicola's practical Alzheimer's-prevention program
If you strip away all the interesting tangents about peptides, psychedelics, Neuralink and experimental therapies, Nicola's actual program is quite conventional—and quite good:
Exercise almost every day. Include regular aerobic work.
Lift weights at least twice weekly. Preserve strength and muscle.
Include some vigorous cardiovascular exercise if medically appropriate.
Control blood pressure.
Control LDL cholesterol/ApoB and cardiovascular risk.
Prevent or treat type 2 diabetes and obesity.
Don't smoke.
Minimize alcohol.
Correct hearing and vision impairment.
Protect your head from repetitive trauma.
Sleep around 7–8 hours consistently.
Remain socially connected.
Keep learning and challenging the brain.
Get appropriate vaccinations, particularly shingles vaccination in the age groups for whom it is recommended.
Then—and importantly, after those fundamentals—she places things such as creatine and omega-3 supplementation.
27. What I think is strongest in the interview
Several parts are especially valuable.
Exercise may be the best "brain supplement."Nicola's argument that aerobic fitness and strength training should be central to brain-health planning is well supported and probably the most important takeaway.
Cardiovascular health and brain health are inseparable.Blood pressure, cholesterol, stroke risk, insulin resistance and obesity deserve enormous attention in anyone concerned about dementia.
Start decades before symptoms.Waiting until serious memory impairment develops is much less useful than controlling risks throughout middle and later life.
Muscle matters.Her emphasis on resistance training, muscle preservation and myokine signaling is one of the distinctive—and increasingly well-supported—aspects of her work. Her own published review addresses this directly.
Creatine and the brain deserve serious attention.The research isn't mature enough to prove dementia prevention, but it's no longer reasonable to think of creatine purely as a bodybuilding supplement. The 20-g/day Alzheimer's pilot makes this an especially interesting research area.
28. Where I would be more cautious than Nicola
There are several claims in the episode that I would put in a different category from her core exercise and cardiovascular recommendations.
"95% of Alzheimer's is lifestyle driven." Too strong. Current best estimates put potentially modifiable dementia burden around 45%.
"The shingles vaccine reduces dementia 50%." Encouraging research exists, but a particularly rigorous natural experiment estimated about a 20% relative reduction.
AI use leads to MCI and Alzheimer's. Interesting hypothesis, not established evidence.
20 g creatine prevents cognitive decline. Promising research, but currently unproved as a long-term preventive treatment.
Very-high-dose EPA/DHA prevents Alzheimer's. Insufficient evidence for that prescription.
Amyloid is mainly an immune response to infection/inflammation. An active hypothesis, not a settled explanation of Alzheimer's.
Exercise clears cancer cells and therefore prevents cancer. Exercise clearly reduces the risk of several cancers and improves outcomes in many circumstances, but the mechanistic story is much more complex.
The interview in one paragraph
Louisa Nicola's message to Shawn Ryan is that Alzheimer's should be fought decades before memory loss occurs by building a resilient brain and a healthy body: exercise frequently, maintain muscle and cardiorespiratory fitness, control blood pressure, cholesterol, obesity and diabetes, sleep well, preserve hearing and vision, remain intellectually and socially engaged, avoid smoking and excessive alcohol, and protect the brain from injury. She views resistance training, aerobic exercise, creatine, omega-3s and shingles vaccination as particularly promising tools and is strongly skeptical of unregulated peptides such as BPC-157. The lifestyle framework is broadly consistent with modern dementia-prevention science, while several of her more dramatic numerical claims—especially that 95% of Alzheimer's is lifestyle-driven, that shingles vaccination reduces risk by 50%, and that high-dose creatine can prevent cognitive decline—go beyond what current clinical evidence can firmly establish.
This Shawn Ryan interview makes clear where she is getting it. The 20-g number comes primarily from the small Alzheimer's pilot, while she discusses roughly 10–12 g/day as a dose intended to meaningfully raise brain creatine in otherwise healthy people. That distinction matters quite a bit.
Published: April 30, 2026
Length: about 3 hours 5 minutes.
The central theme of the interview is Nicola’s argument that the brain should be treated like the rest of the body: something that can be trained, protected, stressed, damaged, and—in many respects—made more resilient. Alzheimer's disease dominates the conversation, but Ryan and Nicola range widely through exercise, sleep, creatine, cholesterol, GLP-1 drugs, menopause, peptides, vaccines, psychedelics, cannabis, traumatic brain injury, social isolation, omega-3s, and emerging neuroscience.
One important caution before getting into her recommendations: Nicola frequently moves from established evidence to plausible mechanisms to personal interpretation without always sharply separating them. Her core message—exercise, control cardiovascular risk, sleep adequately, stay socially and cognitively engaged—is strongly aligned with mainstream dementia-prevention research. Some of her numerical claims and more experimental recommendations are substantially more aggressive.
1. Why Alzheimer's is the centerpiece
Shawn Ryan begins by explaining that Alzheimer's and cancer are two of his greatest health fears and that his grandfather died with Alzheimer's. Nicola responds by emphasizing the enormous and growing burden of dementia and arguing that people make a mistake when they think of Alzheimer's as something that suddenly begins in their seventies or eighties.
Her central concept is that late-life cognitive disease often represents processes occurring for decades before obvious symptoms appear. Therefore, the important period for prevention isn't simply age 70—it is one's 30s, 40s, 50s and 60s.
This leads to perhaps the strongest theme of the entire interview:
Don't wait for memory loss before taking brain health seriously.
She wants people to think about Alzheimer's much as modern medicine thinks about cardiovascular disease: control the underlying risk factors many years before the catastrophic event occurs.
2. Her strongest—and most controversial—claim: Alzheimer's is largely preventable
Nicola tells Ryan that roughly 95% of Alzheimer's cases are lifestyle-driven, contrasting them with a small percentage she attributes primarily to genetics. She uses this to argue that most people have considerable agency over whether they eventually develop the disease.
This is one of the places where I would not take her number literally.
The highly regarded 2024 Lancet Commission concluded that approximately 45% of dementia cases might potentially be prevented or delayed by addressing 14 modifiable risk factors—not 95%. Those risk factors include hypertension, high LDL cholesterol, diabetes, obesity, smoking, physical inactivity, excessive alcohol, hearing loss, untreated vision loss, depression, social isolation and traumatic brain injury.
So her underlying message is well supported:
A remarkably large portion of dementia risk is modifiable.
But saying that 95% of Alzheimer's is essentially a lifestyle choice goes considerably beyond current scientific consensus.
3. Genetics and APOE4
Nicola explains the difference between deterministic genetic mutations and risk genes.
She discusses the rare mutations involving APP, PSEN1 and PSEN2, which can produce familial early-onset Alzheimer's, and contrasts these with APOE4, which greatly increases risk but does not guarantee disease. She notes that inheriting one APOE4 allele raises risk and inheriting two raises it substantially more. Her broader point is that having APOE4 should be viewed as a warning to manage modifiable risks aggressively rather than as a prediction that Alzheimer's is inevitable.
That is an important distinction:
Risk ≠ destiny.
Someone with high genetic susceptibility may never develop dementia, while someone without APOE4 may.
4. Amyloid, tau and what Alzheimer's actually does to the brain
Nicola uses a physical brain model during the interview and gives Ryan a simplified neuroanatomy lesson.
She describes neurons as somewhat like trees:
- the cell body is the central structure,
- the axon resembles the trunk,
- dendrites resemble branches,
- synapses are connections between neurons.
Amyloid-beta accumulates predominantly outside neurons.
Tau becomes abnormal inside neurons.
As these processes progress, synapses fail, neurons become dysfunctional or die, networks lose connectivity, and brain regions important for memory and executive function deteriorate.
She places special emphasis on the hippocampus, an area critical for forming new memories, explaining why short-term and recent memory can become impaired early while very old memories sometimes remain accessible much longer.
5. Nicola challenges a simplistic version of the amyloid hypothesis
One of the more interesting portions of the interview concerns amyloid.
Nicola argues that amyloid-beta isn't simply "garbage" the body mistakenly creates. She describes it as an antimicrobial peptide that may have defensive functions and proposes that inflammation, infection and other forms of physiological stress may stimulate amyloid production.
Her larger question is therefore:
Instead of asking only how we remove amyloid plaques, shouldn't we also ask why amyloid is being produced and accumulating?
This is a legitimate and active area of Alzheimer's research. However, Nicola sometimes talks as though the infection/inflammation explanation has essentially replaced the amyloid hypothesis. It hasn't. Pathogens and immune activation are increasingly studied as possible contributors, but their precise role in Alzheimer's remains unresolved. A 2025 Nature review described the infectious hypothesis as increasingly plausible but still inconclusive.
So this is one of the episode's fascinating areas where the science is developing rather than settled.
6. Cognitive reserve: build a bigger brain "safety margin"
Nicola introduces the concept of cognitive reserve.
The idea is that two people can have similar biological brain pathology yet exhibit very different levels of impairment because one brain has developed more robust neural networks and alternative pathways.
She encourages lifelong:
reading, learning, problem-solving, social interaction, new experiences, intellectually difficult activities and exercise.
She is especially concerned about people becoming cognitively passive after retirement. Her message isn't that retirement itself biologically causes Alzheimer's, but that retirement can remove several protective behaviors simultaneously—daily problem-solving, movement, social interaction, purpose and intellectual stimulation.
That fits well with the broader evidence linking social isolation and reduced cognitive engagement with dementia risk.
7. AI and "brain rot"
Ryan asks whether heavy dependence on AI could impair cognition.
Nicola worries that people are outsourcing mental work—calculations, remembering information, forming arguments, solving problems—and combines this with concerns about endless low-quality social-media scrolling. She compares the brain with muscle: abilities that aren't exercised tend to deteriorate.
She even admits that she once routinely performed mathematics mentally but now catches herself using ChatGPT for calculations she formerly would have done herself.
Where she gets ahead of the evidence is when she suggests this could lead directly toward mild cognitive impairment and ultimately Alzheimer's.
There is not presently evidence establishing that normal use of AI causes Alzheimer's disease.
The useful version of her point is simpler: don't outsource all thinking. Continue reading, calculating, writing, remembering, learning and solving difficult problems.
8. Head trauma, military service and CTE
Because Ryan is a veteran, they spend considerable time discussing traumatic brain injuries.
Nicola emphasizes repeated concussions and TBIs as important long-term neurological risks, mentioning chronic traumatic encephalopathy (CTE) and the cumulative consequences of repeated brain trauma.
She stresses the importance of the period immediately following a concussion and argues strongly for properly managed concussion protocols.
She also broadens the subject beyond obvious head injuries to include hearing damage from explosions and chronic exposure to operational stress.
One particularly useful point is her emphasis on hearing loss. If hearing deteriorates, the brain receives less auditory stimulation, social interaction can decline, and cognitive workload changes. Hearing loss is indeed among the established modifiable dementia risk factors.
9. Women, menopause and Alzheimer's
Nicola devotes a substantial section to the disproportionately high prevalence of Alzheimer's among women.
She points to two broad explanations.
First, women generally live longer, and age is the largest Alzheimer's risk factor.
Second, she emphasizes the neurological importance of estrogen. Rather than thinking of estrogen merely as a reproductive hormone, she describes it as an important neuroendocrine signal involved in brain metabolism, neuronal function and other systems.
She argues that the menopausal transition therefore represents an important period during which women should pay especially close attention to sleep, exercise, muscle, cardiovascular health and metabolic health.
Nicola is generally favorable toward appropriately prescribed menopausal hormone therapy, but makes an interesting distinction: she doesn't present hormone therapy as a magic Alzheimer's drug. Rather, she says reducing hot flashes, sleep disruption, mood changes and loss of muscle may make it easier for women to perform the behaviors that support long-term brain health.
That is a much more nuanced argument than saying "estrogen prevents Alzheimer's."
10. The 14 modifiable dementia risk factors
At roughly 1:50 into the program, Nicola specifically invokes the Lancet dementia work.
Among the things she emphasizes are:
high blood pressure, obesity, type 2 diabetes, smoking, excessive alcohol use, inactivity, high cholesterol, social isolation, hearing loss, vision problems and head injury.
Her practical message is very strong:
A person worried about dementia should spend at least as much attention on blood pressure, LDL/ApoB, glucose, weight, activity and hearing as on exotic "brain supplements."
This may be the most important clinical takeaway from the entire three-hour interview.
11. Exercise is Nicola's number-one brain intervention
This is the heart of her professional work.
Nicola divides exercise into roughly three categories:
Aerobic exercise
High-intensity/VO2-max work
Resistance training
She also includes what she calls neurocognitive or "neuroathletic" training.
She considers exercise the single most powerful readily available intervention because it affects cardiovascular health, insulin sensitivity, body composition, inflammation, mitochondrial function, muscle signaling and brain biology simultaneously.
Nicola's own published research has focused on resistance exercise and brain structure in older adults. Her 2024 review concluded that preliminary evidence suggests resistance exercise can produce structural brain changes associated with lower Alzheimer's risk or slower progression, while acknowledging that better trials are needed.
12. BDNF: "fertilizer for the brain"
Nicola frequently discusses brain-derived neurotrophic factor (BDNF).
BDNF supports neuronal survival, synaptic plasticity and the brain's ability to adapt and form new connections.
She argues that aerobic exercise substantially increases BDNF signaling and therefore helps maintain the brain's ability to remodel itself. Later, when discussing psychedelics, she returns to BDNF as one possible pathway by which certain treatments could alter neural networks.
Her broad analogy is memorable:
Exercise sends a biological signal to the brain saying, "Remain adaptable."
13. High-intensity exercise and lactate
Nicola is particularly enthusiastic about occasional vigorous exercise.
At very high intensities—around Zone 5—the body relies heavily on glycolysis and produces lactate. Contrary to the old idea that lactate is merely metabolic waste, she explains that lactate can serve as an important fuel and signaling molecule, including for the brain.
She therefore sees VO2-max training as having neurological benefits beyond simply strengthening the heart.
She also discusses emerging exercise oncology research and suggests high-intensity exercise may help inhibit tumor progression through several mechanisms. That field is real and exciting, but some of her explanations—such as exercise straightforwardly "clearing circulating tumor cells"—should be regarded as mechanistic interpretations rather than a reason to think vigorous exercise independently treats cancer.
14. Why she cares so much about resistance training
Resistance training receives almost equal billing.
When skeletal muscle contracts strongly, it releases signaling molecules known as myokines. Nicola describes these as biological "care packages" traveling through the bloodstream and influencing the brain, liver, cardiovascular system and other tissues.
She links resistance exercise to:
better insulin sensitivity, improved metabolism, preserved muscle, mitochondrial health, neuroplasticity, healthier aging and possibly reduced neurodegenerative risk.
Her bottom-line recommendation in the interview is at least two resistance-training sessions per week, combined with aerobic exercise and some higher-intensity cardiovascular work.
15. GLP-1 drugs: Nicola is extremely enthusiastic
Nicola calls GLP-1-based medications "remarkable."
She discusses drugs such as semaglutide and tirzepatide and the emerging triple-agonist retatrutide. She thinks their importance goes beyond weight loss because obesity, diabetes and metabolic dysfunction themselves contribute to dementia risk. She also points to reports that GLP-1 therapy can reduce alcohol craving in some people.
Her reasoning is:
If a medication dramatically reduces obesity, insulin resistance and diabetes, it may indirectly improve long-term brain health even if the medication itself isn't an Alzheimer's drug.
Importantly, she acknowledges that simply demonstrating a GLP-1 drug directly prevents dementia has been much harder.
16. Peptides—and why she strongly opposes black-market BPC-157
This is another major section of the episode.
Nicola distinguishes approved peptide drugs from gray-market experimental peptides.
Insulin and GLP-1 drugs are peptides, but they have gone through human clinical trials, manufacturing controls and regulatory review.
BPC-157 is completely different.
She is highly critical of people purchasing BPC-157 from gray- or black-market sources and injecting it for tendon or joint injuries. Her concern isn't simply that it might not work; she worries that users may not know precisely what they are injecting or its long-term effects.
She particularly worries about claims that BPC-157 encourages angiogenesis—the formation of blood vessels. Her concern is theoretical: if something stimulates new vasculature around injured tissue, what would happen if an undetected tumor were also present?
She does not demonstrate in the interview that BPC-157 causes cancer. Her argument is instead:
We don't have enough high-quality human safety data to know that it doesn't create unacceptable risks.
That is a much more accurate way to understand this segment.
She predicts peptides will become increasingly important in medicine but wants them tested and regulated rather than bought online.
17. Shingles vaccination and dementia
This was one of the most striking portions of the episode.
Nicola says shingles vaccination after age 50 may substantially reduce dementia risk and urges older adults to get vaccinated. She explains that varicella-zoster virus remains dormant after chickenpox and can reactivate later as shingles, generating inflammation and potentially interacting with neurological disease.
The underlying research here is genuinely interesting, although she overstates the size of the best-established effect.
She says the reduction may be around 50%. A major 2025 natural experiment published in Nature found approximately a 20% relative reduction in new dementia diagnoses over seven years among people who actually received the older shingles vaccine. Other studies of recombinant Shingrix have also found lower dementia incidence, but randomized dementia-prevention trials have not yet proven that shingles vaccination itself prevents Alzheimer's.
So:
Nicola's direction is supported; the 50% number is too strong as a general claim.
18. Vaccines more broadly
Ryan asks Nicola directly whether she is anti-vaccine.
She says no, emphasizing the enormous historical impact of vaccination against infectious disease. She discusses polio, smallpox, HPV and shingles and expresses concern about broad anti-vaccine sentiment following the COVID era.
She nevertheless says she doesn't believe people should receive vaccinations indiscriminately when they aren't indicated and distinguishes her support for initial COVID vaccination during the pandemic from her views about repeated later boosters.
This section becomes political for a while, including disagreement with RFK Jr. over vaccine policy and discussion of environmental chemicals associated with neurological disease.
19. Cholesterol, LDL/ApoB, statins and brain vascular health
Nicola strongly rejects the idea that keeping LDL cholesterol high is somehow good for the aging brain.
She explains that the brain depends on a healthy vascular system and that cardiovascular disease and cerebrovascular disease share many risk factors. She therefore emphasizes controlling LDL cholesterol and ApoB, particularly in people with cardiovascular risk.
She is generally supportive of statins when medically indicated and rejects claims that statins broadly cause dementia.
This connects to one of her biggest conceptual points: What is good for the arteries is usually good for the brain.
Hypertension, atherosclerosis, stroke, diabetes and vascular injury aren't merely "heart problems." They directly influence cognitive aging.
20. Psychedelics and ibogaine
Ryan discusses his personal experience with ibogaine and reports feeling cognitively sharper afterward.
Nicola finds psychedelic research promising, particularly for PTSD and severe depression, but she is considerably more cautious here than she is about exercise or creatine.
She speculates that neuroplasticity and BDNF might explain some reported benefits, but repeatedly acknowledges that she doesn't fully understand the mechanisms.
She is concerned about the possibility of triggering:
psychosis, schizophrenia-like symptoms or prolonged abnormal mental states in susceptible individuals.
Her position is essentially:
Potentially powerful therapeutic tool—especially in carefully controlled settings—but not something to casually self-administer.
She does not regard psychedelics as a cure for Alzheimer's, although she speculates that future therapeutic "cocktails" might indirectly reduce dementia risk by treating depression, PTSD and other risk factors.
21. Creatine: one of the most important segmentsNear the end
Ryan asks directly:
"So people should be taking creatine?"
Nicola answers yes.
She argues that creatine isn't merely a muscle supplement; the brain also uses the creatine-phosphocreatine system to regenerate ATP.
She says research suggests roughly 10–12 grams/day can raise brain creatine, and discusses larger amounts during neurological stress.
She highlights a particularly intriguing 2025 study in which 20 Alzheimer's patients took 20 g/day of creatine monohydrate for eight weeks. The study reported increased brain creatine and encouraging cognitive findings.
This study really does exist.
But there is a major limitation Nicola doesn't emphasize enough:
It was a small, single-arm pilot trial—not a randomized placebo-controlled demonstration that creatine treats Alzheimer's.So it is promising evidence, not proof.
Her argument that the brain needs larger amounts of creatine than muscle to meaningfully raise cerebral creatine levels is biologically plausible and increasingly studied. Her leap from that evidence to recommending high chronic doses for everyone is more speculative.
22. Creatine and sleep deprivation
Nicola also discusses research showing that a large dose of creatine can improve cognitive performance during acute sleep deprivation.
She goes so far as to say a ~15-g bolus can almost compensate cognitively for a bad night's sleep.
That's an intriguing experimental finding, but it does not mean creatine replaces sleep.
The sensible interpretation is that improving cerebral energy availability may partly preserve cognition under metabolic stress.
23. Sleep is non-negotiable
Sleep is one of Nicola's major pillars.
She describes deep sleep as a period of restoration and waste clearance and advocates approximately 7½ hours of sleep nightly. She recommends lowering household lighting in the evening and personally favors dim or red illumination before bed to facilitate the transition into sleep.
She repeatedly links inadequate sleep with:
impaired cognition, metabolic dysfunction, elevated stress signaling and potentially impaired clearance of proteins associated with neurodegeneration.
Whatever one thinks of the details of the amyloid mechanism, her overall conclusion is very well grounded:
Chronic inadequate sleep is bad for cognitive and cardiovascular health.
24. Marijuana
Nicola is considerably more negative about THC.
She argues that people often mistake sedation for high-quality sleep and says marijuana may interfere with normal sleep architecture, particularly REM and deep sleep. She also points to the risk of psychosis with heavy cannabis exposure in susceptible people.
She distinguishes THC from CBD, noting CBD's established medical use in certain epilepsy syndromes.
Her description of marijuana as simply "terrible" is broader than the scientific evidence warrants, but the distinction between feeling sedated and achieving normal restorative sleep is an important one.
25. Omega-3s
At the end of the interview, Nicola strongly recommends EPA and DHA.
She stresses the large amount of lipid in the nervous system and the importance of DHA to neuronal membranes. She also cautions that poor-quality fish-oil supplements can become oxidized.
She gives a very aggressive intake recommendation—approximately 2 g DHA plus 2 g EPA daily.
That is not a universal clinical guideline for preventing Alzheimer's and is substantially more than many people consume through standard supplements. Someone contemplating that dose, particularly while using anticoagulant or antiplatelet drugs, should treat it as something to discuss with a clinician rather than simply adopting Nicola's dose.
26. Nicola's practical Alzheimer's-prevention program
If you strip away all the interesting tangents about peptides, psychedelics, Neuralink and experimental therapies, Nicola's actual program is quite conventional—and quite good:
Exercise almost every day. Include regular aerobic work.
Lift weights at least twice weekly. Preserve strength and muscle.
Include some vigorous cardiovascular exercise if medically appropriate.
Control blood pressure.
Control LDL cholesterol/ApoB and cardiovascular risk.
Prevent or treat type 2 diabetes and obesity.
Don't smoke.
Minimize alcohol.
Correct hearing and vision impairment.
Protect your head from repetitive trauma.
Sleep around 7–8 hours consistently.
Remain socially connected.
Keep learning and challenging the brain.
Get appropriate vaccinations, particularly shingles vaccination in the age groups for whom it is recommended.
Then—and importantly, after those fundamentals—she places things such as creatine and omega-3 supplementation.
27. What I think is strongest in the interview
Several parts are especially valuable.
Exercise may be the best "brain supplement."Nicola's argument that aerobic fitness and strength training should be central to brain-health planning is well supported and probably the most important takeaway.
Cardiovascular health and brain health are inseparable.Blood pressure, cholesterol, stroke risk, insulin resistance and obesity deserve enormous attention in anyone concerned about dementia.
Start decades before symptoms.Waiting until serious memory impairment develops is much less useful than controlling risks throughout middle and later life.
Muscle matters.Her emphasis on resistance training, muscle preservation and myokine signaling is one of the distinctive—and increasingly well-supported—aspects of her work. Her own published review addresses this directly.
Creatine and the brain deserve serious attention.The research isn't mature enough to prove dementia prevention, but it's no longer reasonable to think of creatine purely as a bodybuilding supplement. The 20-g/day Alzheimer's pilot makes this an especially interesting research area.
28. Where I would be more cautious than Nicola
There are several claims in the episode that I would put in a different category from her core exercise and cardiovascular recommendations.
"95% of Alzheimer's is lifestyle driven." Too strong. Current best estimates put potentially modifiable dementia burden around 45%.
"The shingles vaccine reduces dementia 50%." Encouraging research exists, but a particularly rigorous natural experiment estimated about a 20% relative reduction.
AI use leads to MCI and Alzheimer's. Interesting hypothesis, not established evidence.
20 g creatine prevents cognitive decline. Promising research, but currently unproved as a long-term preventive treatment.
Very-high-dose EPA/DHA prevents Alzheimer's. Insufficient evidence for that prescription.
Amyloid is mainly an immune response to infection/inflammation. An active hypothesis, not a settled explanation of Alzheimer's.
Exercise clears cancer cells and therefore prevents cancer. Exercise clearly reduces the risk of several cancers and improves outcomes in many circumstances, but the mechanistic story is much more complex.
The interview in one paragraph
Louisa Nicola's message to Shawn Ryan is that Alzheimer's should be fought decades before memory loss occurs by building a resilient brain and a healthy body: exercise frequently, maintain muscle and cardiorespiratory fitness, control blood pressure, cholesterol, obesity and diabetes, sleep well, preserve hearing and vision, remain intellectually and socially engaged, avoid smoking and excessive alcohol, and protect the brain from injury. She views resistance training, aerobic exercise, creatine, omega-3s and shingles vaccination as particularly promising tools and is strongly skeptical of unregulated peptides such as BPC-157. The lifestyle framework is broadly consistent with modern dementia-prevention science, while several of her more dramatic numerical claims—especially that 95% of Alzheimer's is lifestyle-driven, that shingles vaccination reduces risk by 50%, and that high-dose creatine can prevent cognitive decline—go beyond what current clinical evidence can firmly establish.
This Shawn Ryan interview makes clear where she is getting it. The 20-g number comes primarily from the small Alzheimer's pilot, while she discusses roughly 10–12 g/day as a dose intended to meaningfully raise brain creatine in otherwise healthy people. That distinction matters quite a bit.